A sex-specific role for androgens in angiogenesis

Journal of Experimental Medicine

Volumn 207, Issue 2, 2010, Pages 345-352

  Sieveking, Daniel P ^a,b   Lim, Patrick ^a   Chow, Renée W Y ^a   Dunn, Louise L ^a   Bao, Shisan ^b   McGrath, Kristine C Y ^a   Heather, Alison K ^a   Handelsman, David J ^c,d   Celermajer, David S ^a,b,e   Ng, Martin K C ^a,b,e  

^a HEART RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ANZAC RESEARCH INSTITUTE   (Australia)

^d ANZAC Research Institute   (Australia)

^e ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; SMALL INTERFERING RNA; VASCULOTROPIN; ANDROGEN RECEPTOR ANTAGONIST;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HINDLIMB; LIMB ISCHEMIA; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; ORCHIECTOMY; OVARIECTOMY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TISSUE REGENERATION; TISSUE REPAIR; UMBILICAL VEIN; ANIMAL; BIOSYNTHESIS; CARDIOVASCULAR DISEASES; CASTRATION; CONVALESCENCE; DRUG EFFECTS; HUMAN; ISCHEMIA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

ANDROGEN RECEPTOR ANTAGONISTS; ANIMALS; CARDIOVASCULAR DISEASES; CASTRATION; DIHYDROTESTOSTERONE; ENDOTHELIAL CELLS; FEMALE; HINDLIMB; HUMANS; ISCHEMIA; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, ANDROGEN; RECOVERY OF FUNCTION; SEX FACTORS;

EID: 77149144520     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20091924     Document Type: Article

References (39)

1. Abaci, A., A. Oǧuzhan, S. Kahraman, N.K. Eryol, S. Unal, H. Arinç, and A. Ergin. 1999. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 99:2239-2242.
2. Akane, A. 1998. Sex determination by PCR analysis of the X-Y amelogenin gene. Methods Mol. Biol. 98:245-249.
3. Araujo, A.B., V. Kupelian, S.T. Page, D.J. Handelsman, W.J. Bremner, and J.B. McKinlay. 2007. Sex steroids and all-cause and cause-specific mortality in men. Arch. Intern. Med. 167:1252-1260. doi:10.1001/archinte.167.12.1252
4. Asahara, T., T. Murohara, A. Sullivan, M. Silver, R. van der Zee, T. Li, B. Witzenbichler, G. Schatteman, and J.M. Isner. 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:964-967. doi:10.1126/science.275.5302.964
5. Boddy, J.L., S.B. Fox, C. Han, L. Campo, H. Turley, S. Kanga, P.R. Malone, and A.L. Harris. 2005. The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clin. Cancer Res. 11:7658-7663. doi:10.1158/1078-0432. CCR-05-0460
6. Carmeliet, P. 2005. Angiogenesis in life, disease and medicine. Nature. 438:932-936. doi:10.1038/nature04478
7. Ceradini, D.J., and G.C. Gurtner. 2005. Homing to hypoxia: HIF-1 as a mediator of progenitor cell recruitment to injured tissue. Trends Cardiovasc. Med. 15:57-63. doi:10.1016/j.tcm.2005.02.002
8. Ceradini, D.J., A.R. Kulkarni, M.J. Callaghan, O.M. Tepper, N. Bastidas, M.E. Kleinman, J.M. Capla, R.D. Galiano, J.P. Levine, and G.C. Gurtner. 2004. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat. Med. 10:858-864. doi:10.1038/nm1075
9. Couffinhal, T., M. Silver, L.P. Zheng, M. Kearney, B. Witzenbichler, and J.M. Isner. 1998. Mouse model of angiogenesis. Am. J. Pathol. 152:1667-1679.
10. Death, A.K., K.C. McGrath, M.A. Sader, S. Nakhla, W. Jessup, D.J. Handelsman, and D.S. Celermajer. 2004. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. Endocrinology. 145:1889-1897. doi:10.1210/en.2003-0789
11. Ferrara, N., H.P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9:669-676. doi:10.1038/nm0603-669
12. Harman, S.M. 2005. Testosterone in older men after the Institute of Medicine Report: where do we go from here? Climacteric. 8:124-135. doi:10.1080/13697130500042417
13. Heeschen, C., A. Aicher, R. Lehmann, S. Fichtlscherer, M. Vasa, C. Urbich, C. Mildner-Rihm, H. Martin, A.M. Zeiher, and S. Dimmeler. 2003. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood. 102:1340-1346. doi:10.1182/blood-2003-01-0223
14. Heil, M., T. Ziegelhoeffer, B. Mees, and W. Schaper. 2004. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ. Res. 94:573-574. doi:10.1161/01.RES.0000124603.46777.EB
15. Iwakura, A., S. Shastry, C. Luedemann, H. Hamada, A. Kawamoto, R. Kishore, Y. Zhu, G. Qin, M. Silver, T. Thorne, et al. 2006. Estradiol enhances recovery after myocardial infarction by augmenting incorporation of bone marrow-derived endothelial progenitor cells into sites of ischemia-induced neovascularization via endothelial nitric oxide synthase-mediated activation of matrix metalloproteinase-9. Circulation. 113:1605-1614. doi:10.1161/CIRCULATIONAHA.105.553925
16. Jin, D.K., K. Shido, H.G. Kopp, I. Petit, S.V. Shmelkov, L.M. Young, A.T. Hooper, H. Amano, S.T. Avecilla, B. Heissig, et al. 2006. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat. Med. 12:557-567. doi:10.1038/nm1400
17. Joseph, J., and M. Dyson. 1965. Sex differences in the rate of tissue regeneration in the rabbit's ear. Nature. 208:599-600. doi:10.1038/208599a0
18. Kennedy, B.J., and A.S. Gilbertsen. 1957. Increased erythropoiesis induced by androgenic-hormone therapy. N. Engl. J. Med. 256:719-726.
19. Khaw, K.T., M. Dowsett, E. Folkerd, S. Bingham, N. Wareham, R. Luben, A. Welch, and N. Day. 2007. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation. 116:2694-2701. doi:10.1161/CIRCULATIONAHA.107.719005
20. Laughlin, G.A., E. Barrett-Connor, and J. Bergstrom. 2008. Low serum testosterone and mortality in older men. J. Clin. Endocrinol. Metab. 93:68-75. doi:10.1210/jc.2007-1792
21. Liu, P.Y., A.K. Death, and D.J. Handelsman. 2003. Androgens and cardiovascular disease. Endocr. Rev. 24:313-340. doi:10.1210/er.2003-0005
22. Losordo, D.W., and J.M. Isner. 2001. Estrogen and angiogenesis: A review. Arterioscler. Thromb. Vasc. Biol. 21:6-12.
23. McCrohon, J.A., W. Jessup, D.J. Handelsman, and D.S. Celermajer. 1999. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of vascular cell adhesion molecule-1. Circulation. 99:2317-2322.
24. McCrohon, J.A., A.K. Death, S. Nakhla, W. Jessup, D.J. Handelsman, K.K. Stanley, and D.S. Celermajer. 2000. Androgen receptor expression is greater in macrophages from male than from female donors. A sex difference with implications for atherogenesis. Circulation. 101:224-226.
25. Morales, D.E., K.A. McGowan, D.S. Grant, S. Maheshwari, D. Bhartiya, M.C. Cid, H.K. Kleinman, and H.W. Schnaper. 1995. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation. 91:755-763.
26. Ng, M.K., W. Jessup, and D.S. Celermajer. 2001. Sex-related differences in the regulation of macrophage cholesterol metabolism. Curr. Opin. Lipidol. 12:505-510. doi:10.1097/00041433-200110000-00005
27. Ng, M.K., S. Nakhla, A. Baoutina, W. Jessup, D.J. Handelsman, and D.S. Celermajer. 2003a. Dehydroepiandrosterone, an adrenal androgen, increases human foam cell formation: a potentially pro-atherogenic effect. J. Am. Coll. Cardiol. 42:1967-1974. doi:10.1016/j.jacc.2003.07.024
28. Ng, M.K., C.M. Quinn, J.A. McCrohon, S. Nakhla, W. Jessup, D.J. Handelsman, D.S. Celermajer, and A.K. Death. 2003b. Androgens upregulate atherosclerosis-related genes in macrophages from males but not females: molecular insights into gender differences in atherosclerosis. J. Am. Coll. Cardiol. 42:1306-1313. doi:10.1016/j.jacc.2003.07.002
29. Passaniti, A., R.M. Taylor, R. Pili, Y. Guo, P.V. Long, J.A. Haney, R.R. Pauly, D.S. Grant, and G.R. Martin. 1992. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Invest. 67:519-528.
30. Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. doi:10.1093/nar/29.9.e45
31. Sasaki, S., T. Inoguchi, K. Muta, Y. Abe, M. Zhang, K. Hiasa, K. Egashira, N. Sonoda, K. Kobayashi, R. Takayanagi, and H. Nawata. 2007. Therapeutic angiogenesis by ex vivo expanded erythroid progenitor cells. Am. J. Physiol. Heart Circ. Physiol. 292:H657-H665. doi:10.1152/ajpheart.00343. 2006
32. Semenza, G.L. 2002. HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol. Med. 8(Suppl.):S62-S67. doi:10.1016/S1471- 4914(02)02317-1
33. Shaw, L.J., C.N. Bairey Merz, C.J. Pepine, S.E. Reis, V. Bittner, S.F. Kelsey, M. Olson, B.D. Johnson, S. Mankad, B.L. Sharaf, et al; WISE Investigators. 2006. Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J. Am. Coll. Cardiol. 47(Suppl. 1):S4-S20. doi:10.1016/j.jacc.2005.01.072
34. Sieveking, D.P., and M.K. Ng. 2009. Cell therapies for therapeutic angiogenesis: back to the bench. Vasc. Med. 14:153-166. doi:10.1177/1358863X08098698
35. Sieveking, D.P., A. Buckle, D.S. Celermajer, and M.K. Ng. 2008. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J. Am. Coll. Cardiol. 51:660-668. doi:10.1016/j.jacc.2007.09.059
36. Stabile, E., M.S. Burnett, C. Watkins, T. Kinnaird, A. Bachis, A. la Sala, J.M. Miller, M. Shou, S.E. Epstein, and S. Fuchs. 2003. Impaired arteriogenic response to acute hindlimb ischemia in CD4-knockout mice. Circulation. 108:205-210. doi:10.1161/01.CIR.0000079225.50817.71
37. Tivesten, A., L. Vandenput, F. Labrie, M.K. Karlsson, O. Ljunggren, D. Mellström, and C. Ohlsson. 2009. Low serum testosterone and estradiol predict mortality in elderly men. J. Clin. Endocrinol. Metab. 94:2482-2488.
38. Wingard, D.L., L. Suarez, and E. Barrett-Connor. 1983. The sex differential in mortality from all causes and ischemic heart disease. Am. J. Epidemiol. 117:165-172.
39. Wu, F.C., and A. von Eckardstein. 2003. Androgens and coronary artery disease. Endocr. Rev. 24:183-217. doi:10.1210/er.2001-0025